NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: American Heart Association's New Guidance for Responsible AI Use in Health Care
TL;DR
The American Heart Association's new AI framework gives health systems a strategic advantage by ensuring AI tools deliver measurable clinical benefits while managing risks.
The American Heart Association's advisory outlines a risk-based framework with four principles for evaluating and monitoring AI tools in cardiovascular care.
This guidance helps ensure AI tools improve patient outcomes and support equitable, high-quality care across diverse populations and healthcare settings.
Only 61% of hospitals validate AI tools on local data before deployment, highlighting the need for ongoing monitoring as clinical practices evolve.
Found this article helpful?
Share it with your network and spread the knowledge!
The advisory provides a pragmatic, risk-based framework to help health systems build effective AI governance for selecting, validating, implementing, and overseeing AI tools in cardiovascular and stroke care.
AI is transforming health care faster than traditional evaluation frameworks can keep up, and many AI tools are deployed without rigorous local validation or bias assessment, raising concerns about consistent care delivery and patient safety.
The four principles are strategic alignment, ethical evaluation, usefulness and effectiveness, and financial performance, which help ensure AI tools deliver measurable clinical benefit while safeguarding individuals from known and unknown harms.
A recent survey found that only 61% of hospitals using predictive AI tools validated them on local data prior to deployment, and fewer than half tested for bias, with this variability being most pronounced among smaller, rural and non-academic institutions.
The American Heart Association, with Dr. Sneha S. Jain as volunteer vice chair of the writing group, leads this initiative and brings extensive experience through their network of nearly 3,000 hospitals participating in Get With The Guidelines® quality improvement programs.
The advisory was published in the Association's flagship journal Circulation and was released on November 10, 2025, under embargo until 4:00 am CT/5:00 am ET.
The advisory identifies critical gaps in current practices, noting that while hundreds of health care AI tools have been FDA-cleared, only a fraction are rigorously evaluated for clinical impact, fairness, or bias, and FDA review covers only a small portion of health AI tools being developed.
The Association has committed over $12 million in research funding to study the use of AI in addressing cardiovascular disease and maintains an extensive hospital network that positions it as a trusted leader in advancing responsible AI governance.
Curated from NewMediaWire
